{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:29:11Z","timestamp":1775064551615,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>Since the first implantation in July 2001, the intrathecal baclofen (ITB) therapy for patients with generalized spasticity has been used in Slovenia for 20 years. The aim of this retrospective study was to evaluate the rates of different complications, especially if catheter-related complications were less frequent after the introduction of the coated catheter type in February 2013, and the potential correlation between higher baclofen doses and the incidence of complications. We retrospectively collected data from all patients in the registry during the period from 3 July 2001 to 31 December 2021. Among 138 patients (48 females), 120 patients had the first ITB system implanted at the University Medical Centre Ljubljana. Forty-three complications were reported in 38 patients (27%), with a total complication rate of 0.203\/1000 days or 0.074\/pump year. The most frequent was catheter-related (0.083\/1000 days or 0.030\/pump year), followed by skin-related (0.063\/1000 days or 0.023\/pump year) and pump-related complication (0.026\/1000 days or 0.009\/pump year). The incidence of catheter-related complications decreased significantly since the use of Ascenda type catheter: 14\/7 complications per 88\/147 implantations (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.008). Patients with complications had a statistically significantly higher dose of baclofen: median 400 \u00b5g\/24h vs. median 300 \u00b5g\/24h (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.016). Our retrospective analysis confirmed a significant decrease of catheter-related complications after the implementation of Ascenda type catheter in February 2013. Patients with a higher ITB dose had a statistically significantly higher incidence of complications. The total complication rate was a bit higher as previously reported in other studies, which is consistent with a long follow-up time.<\/jats:p>","DOI":"10.1097\/mrr.0000000000000586","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T03:56:35Z","timestamp":1687578995000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Twenty years of intrathecal baclofen therapy in Slovenia: a retrospective single-center analysis of complications"],"prefix":"10.1097","volume":"46","author":[{"given":"Mitja","family":"Benedi\u010di\u010d","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Groleger Sr\u0161en","sequence":"additional","affiliation":[{"name":"Department for rehabilitation, University Rehabilitation Institute of Republic Slovenia \u2013 So\u010da"},{"name":"University Ljubljana, Medical Faculty, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klemen","family":"Grabljevec","sequence":"additional","affiliation":[{"name":"Department for rehabilitation, University Rehabilitation Institute of Republic Slovenia \u2013 So\u010da"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ne\u017ea","family":"Majdi\u010d","sequence":"additional","affiliation":[{"name":"Department for rehabilitation, University Rehabilitation Institute of Republic Slovenia \u2013 So\u010da"},{"name":"University Ljubljana, Medical Faculty, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Haber","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Centre Ljubljana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ner.12447","article-title":"Best practices for intrathecal baclofen therapy: patient selection.","volume":"19","author":"Saulino","year":"2016","journal-title":"Neuromodulation"},{"key":"R2-20250525","first-page":"174","article-title":"Intrathecal delivery of baclofen as functional treatment of severe spasticity.","volume":"28","author":"Grabljevec","year":"2016","journal-title":"Fiz Rehabil Med"},{"key":"R3-20250525","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.spen.2010.10.009","article-title":"Pharmacologic treatment of spasticity in children.","volume":"17","author":"Tilton","year":"2010","journal-title":"Semin Pediatr Neurol"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0028-3908(85)90075-9","article-title":"[3 H](-)Baclofen: an improved ligand for GABAB sites.","volume":"24","author":"Bowery","year":"1985","journal-title":"Neuropharmacology"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/jns.1993.78.2.0226","article-title":"Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.","volume":"78","author":"Coffey","year":"1993","journal-title":"J Neurosurg"},{"issue":"Pt 1","key":"R6-20250525","first-page":"173","article-title":"Intrathecal baclofen therapy in patients with severe spasticity.","volume":"97","author":"Marra","year":"2007","journal-title":"Acta Neurochir Suppl"},{"key":"R7-20250525","first-page":"jrm00241","article-title":"European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and\/or botulinum toxin type A.","volume":"54","author":"Biering-Soerensen","year":"2022","journal-title":"J Rehabil Med"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1545968310363585","article-title":"Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review.","volume":"24","author":"Stetkarova","year":"2010","journal-title":"Neurorehabil Neural Repair"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00002060-200011000-00010","article-title":"Intrathecal baclofen pump use for spasticity: a clinical survey.","volume":"79","author":"Stempien","year":"2000","journal-title":"Am J Phys Med Rehabil"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpn.2022.02.002","article-title":"Surgical complications of intrathecal baclofen in children: a single centre, 20-year retrospective cohort study.","volume":"37","author":"Bonouvri\u00e9","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3171\/2013.11.PEDS13253","article-title":"Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience.","volume":"13","author":"Motta","year":"2014","journal-title":"J Neurosurg Pediatr"},{"key":"R12-20250525","first-page":"78","article-title":"Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients.","volume":"50","author":"Coffey","year":"2002","journal-title":"Neurosurgery"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1526-4637.2002.02048.x","article-title":"Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data.","volume":"3","author":"Yaksh","year":"2002","journal-title":"Pain Med"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/ner.12481","article-title":"Primary hydromorphone-related intrathecal catheter tip granulomas: is there a role for dose and concentration?","volume":"19","author":"Veizi","year":"2016","journal-title":"Neuromodulation"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/ner.12467","article-title":"Best practices for intrathecal baclofen therapy: troubleshooting.","volume":"19","author":"Saulino","year":"2016","journal-title":"Neuromodulation"},{"key":"R16-20250525","first-page":"49","article-title":"Pressure sores: a risk assessment card.","volume":"81","author":"Waterlow","year":"1985","journal-title":"Nurs Times"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"e00965","DOI":"10.1002\/brb3.965","article-title":"Eleven years\u2019 experience with intrathecal baclofen - complications, risk factors.","volume":"8","author":"Pucks-Faes","year":"2018","journal-title":"Brain Behav"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpn.2009.05.002","article-title":"Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity.","volume":"14","author":"Dan","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1177\/1352458520936912","article-title":"Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: a single-center experience.","volume":"27","author":"Abbatemarco","year":"2021","journal-title":"Mult Scler"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.apmr.2013.12.019","article-title":"Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.","volume":"95","author":"Borrini","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"575168","DOI":"10.5402\/2012\/575168","article-title":"Complications of intrathecal baclofen pump: prevention and cure.","volume":"2012","author":"Awaad","year":"2012","journal-title":"ISRN Neurol"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1038\/scsandc.2017.57","article-title":"Effective management of spasticity and impacts on weight change and resting energy expenditure in a female with spinal cord injury: a case report.","volume":"3","author":"Nevin","year":"2017","journal-title":"Spinal Cord Ser Cases"}],"container-title":["International Journal of Rehabilitation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:05:33Z","timestamp":1748203533000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mrr.0000000000000586","relation":{},"ISSN":["0342-5282"],"issn-type":[{"value":"0342-5282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}